Relationships and host range of human, canine, simian and porcine isolates of simian virus 5 (parainfluenza virus 5) Sequence comparison of the V/P and F genes of 13 human, canine, porcine and simian isolates of simian virus 5 (SV5) revealed a surprising lack of sequence variation at both the nucleotide and amino acid levels (0-3 %), even though the viruses were isolated over 30 years and originated from countries around the world. Furthermore, there were no clear distinguishing amino acid or nucleotide differences among the isolates that correlated completely with the species from which they were isolated. In addition, there was no evidence that the ability of the viruses to block interferon signalling by targeting STAT1 for degradation was confined to the species from which they were isolated. All isolates had an extended cytoplasmic tail in the F protein, compared with the original W3A and WR monkey isolates. Sequence analysis of viruses that were derived from human bone-marrow cells isolated in London in the 1980s revealed that, whilst they were related more closely to one another than to the other isolates, they all had identifying differences, suggesting that they were independent isolates. These results therefore support previous data suggesting that SV5 can infect humans persistently, although the relationship of SV5 to any human disease remains highly contentious. Given that SV5 has been isolated on multiple occasions from different species, it is proposed that the term simian virus 5 is inappropriate and suggested that the virus should be renamed parainfluenza virus 5.
INTRODUCTION
Simian virus type 5 (SV5) is in the genus Rubulavirus of the subfamily Paramyxovirinae of the family Paramyxoviridae. SV5 was first isolated from rhesus and cynomolgus monkey kidney-cell cultures and two of the original monkey isolates are referred to as WR and W3A (Hull et al., 1956; Choppin, 1964) . It was thus thought initially that monkeys were the natural host for SV5, but epidemiological studies in the 1960s showed that wild monkeys do not have antibodies against the virus. However, these animals seroconvert in captivity and, on this basis, it was suggested that infection of monkeys occurs either in transit or shortly after contact with humans (Tribe, 1966; Atoynatan & Hsiung, 1969; Hsiung, 1972) . Indeed, Tribe (1966) suggested that monkeys that were brought into captivity should be immunized immediately against SV5 to prevent them being infected with the virus. There is also experimental evidence supporting the contention that SV5 naturally infects humans (Hsiung, 1972; Goswami et al., 1984) . For example, SV5 has been isolated on numerous occasions from a variety of human tissues, including bone-marrow cells (Goswami et al., 1984) . Despite this, infection of humans with SV5 has remained a subject of some debate and controversy, fuelled by the fact that SV5 can contaminate primary monkey kidney-cell cultures (and other cell lines), which are commonly used to isolate viruses from clinical samples (Chanock et al., 1961; Hsiung, 1972; Huddlestone et al., 1979; Wallen et al., 1979; Choppin, 1981) . Furthermore, antigenic cross-reactions occur between SV5 and known human paramyxoviruses, including human parainfluenza virus type 2 (Randall & Young, 1988; Tsurudome et al., 1989) , making interpretation of the earlier seroepidemiological studies difficult (Hsiung, 1972) . No acute human disease has been linked reproducibly to infection with SV5, although it has been suggested that SV5 may be a possible cause of some cases of multiple sclerosis Russell et al., 1989) . However, this contention has largely been dismissed, as its findings have not been supported by subsequent studies (McLean & Thompson, 1989; Vandvik & Norrby, 1989) . It is accepted that SV5 (or canine parainfluenza virus, as it is IP: 54.70.40.11
On: Sun, 30 Dec 2018 07:08:29 more often referred to in a veterinary context) is a natural cause of the respiratory illness kennel cough in dogs (Binn et al., 1967; Rosenberg et al., 1971; Cornwell et al., 1976; McCandlish et al., 1978; Azetaka & Konishi, 1988) . SV5 has also been isolated from a dog with temporary posterior paralysis (Evermann et al., 1980) and this isolate, termed CPI+, caused acute encephalitis when injected intracranially into gnotobiotic dogs (Baumgärtner et al., 1981) . From one such experimentally infected dog, a variant, termed CPI2, was isolated that had phenotypic and genotypic differences (see below) from CPI+ (Baumgärtner et al., 1982 (Baumgärtner et al., , 1987a (Baumgärtner et al., , b, 1991 Southern et al., 1991; Chatziandreou et al., 2002) . Several other canine isolates of SV5 have been isolated and studied, including the T1 isolate (Azetaka & Konishi, 1988; Ito et al., 2000) . In addition, an isolate of SV5, termed SER, was isolated recently from the lung of a fetus of a breeding sow with porcine respiratory and reproductive syndrome (Heinen et al., 1998; Tong et al., 2002) . There is also evidence that cats, hamsters and guinea pigs may naturally be infected with SV5 or a very closely related virus (Hsiung, 1972) .
SV5 has a single-stranded, non-segmented, negative-sense RNA genome of 15 246 nt (for isolate W3A), which contains seven genes that encode eight proteins [NP, P and V, M, F, SH, HN and L; for a review of the molecular biology of paramyxoviruses, see Lamb & Kolakofsky (2001) ]. The ability to encode eight proteins from seven genes occurs because the V/P gene contains two overlapping open reading frames that give rise to two distinct gene products as a result of RNA editing. These two structural proteins are termed V and P and they have the first 164 aa of the Nterminus in common. However, as a consequence of RNA editing (resulting in the addition of two G residues at the editing site), the reading frames of the mRNAs that encode the two proteins differ past this point and the proteins thus have unique C-terminal domains (Thomas et al., 1988) . The P protein forms part of the viral polymerase complex, whilst the V protein is a multifunctional protein that: (i) blocks interferon (IFN) signalling by targeting STAT1 for proteasome-mediated degradation (Didcock et al., 1999a, b; Young et al., 2000; Andrejeva et al., 2002; Parisien et al., 2002; Ulane & Horvath, 2002) ; (ii) inhibits IFN production by an as yet uncharacterized mechanism Poole et al., 2002; Wansley & Parks, 2002) ; and (iii) binds to soluble, but not polymeric, NP and may thus have a role in the control of virus replication and encapsidation (Randall & Bermingham, 1996) .
The interaction of viruses with the IFN system is one of the critical factors that determine the outcome of acute virus infections (Stark et al., 1998; Goodbourn et al., 2000; Levy & Garcia-Sastre, 2001; Biron & Sen, 2001; Sen, 2001 ). However, there may be other more subtle consequences of the interaction of viruses with the IFN system. Thus, we have suggested that the ability of paramyxoviruses to establish persistent infections in vivo may be linked to their ability, or not, to block the IFN response (Chatziandreou et al., 2002) .
The ability of viruses to circumvent the IFN response may also be one factor that limits their host range. For example, SV5 fails to block IFN signalling in mouse cells (Didcock et al., 1999a) and is non-pathogenic in normal and severe combined immunodeficient (SCID) mice (Young et al., 1990; Didcock et al., 1999a) . However, SV5 is lethal in STAT1-knockout mice, i.e. mice that cannot respond to IFN (He et al., 2001 . Given the suggestion that IFN sensitivity may influence the ability of SV5 to establish persistent infections and that the sensitivity of paramyxoviruses to IFN may limit their host range (Didcock et al., 1999a; Parisien et al., 2002; Park et al., 2003) , we undertook this study to compare the ability of different human, simian, canine and porcine isolates of SV5 to block IFN signalling in human and dog cells. Furthermore, we cloned and sequenced both the P/V and F genes of these viruses to see whether there were obvious correlates of sequence diversity with the species from which they were isolated.
METHODS
Cells and viruses. 2fTGH and HEp2 (human), Madin-Darby canine kidney (MDCK) (canine) and Vero (monkey) cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10 % fetal calf serum. Canine variants of SV5 included isolates H221 and 78524 (obtained from O. Jarrett, Faculty of Veterinary Medicine, University of Glasgow, UK) and CPI+ and CPI2 (Evermann et al., 1981; Baumgärtner et al., 1981) . The human bonemarrow isolates used were MIL, DEN, LN and MEL (Goswami et al., 1984) . The porcine SER isolate (Heinen et al., 1998) was obtained from H. D. Klenk (Philipps-Universität Marburg, Germany). Virus stocks were prepared and titrated by using Vero cells.
Cloning and sequencing of the V and F genes. 2fTGH or MDCK cells were infected or mock-infected with the appropriate isolate of SV5 and at 21 h post-infection (p.i.), the medium was replaced with serum-free medium. At 30 h p.i., this medium (containing progeny virus) was harvested, pelleted by ultracentrifugation (30 000 r.p.m. for 90 min in a Beckman SW50 rotor) and viral RNA was isolated by using a Qiagen RNeasy RNA extraction kit. cDNA was prepared from viral RNA by using reverse primers that were specific to the P/V or F gene (outside the coding regions) and Moloney murine leukaemia virus reverse transcriptase (Promega). The products of these reactions were used in PCRs with Pfu polymerase (Promega), using forward and reverse primers that were specific to either the P/V or F genes to generate full-length P/V and F gene products. These were then cloned into the pGATA (P/V) or pGEM T-Easy (F) vectors and sequenced by using an automated sequencer and internal oligonucleotides, to ensure that the sequence was covered in both directions.
Phylogenetic analysis. Alignments of the sets of DNA sequences representing the F and V/P genes of isolates were made; for the latter, the two G residues that were introduced during synthesis of the P mRNA were included in each sequence. Phylogenetic analysis was carried out by using the program MrBayes 3 (Ronquist & Huelsenbeck, 2003) , which applies Bayesian inference with Markov chain Monte Carlo techniques. From an input starting tree (chosen randomly in our application), the method involves successive perturbations of the current tree by a procedure picked stochastically from a range specifying different alterations in tree topology or branch-lengths, followed by a statistical test that is based on the fit of the input alignment to the new tree to decide whether to accept or reject that tree as the input for the next cycle of the process. The arrangements for choice of perturbation at each stage and for acceptance of the current tree are constructed in such a way that the output list of accepted trees should converge to represent the posterior probability distribution of trees contingent on the input alignment. A recent review of Bayesian methods in phylogenetic analysis is given by Huelsenbeck et al. (2001) . By using standard options of the program, the general time-reversible model of nucleotide substitution was employed and rates of change across alignment sites were modelled by a discrete gamma distribution plus an invariant category. The sets of alignment loci that represented the first, second and third codon positions were assigned to separate partitions in the analysis. Each program run included one 'cold' and three 'heated' chains (the latter are a device to aid rapid convergence of the process) and proceeded for 2610 6 generations, with sampling of trees every 100 generations. Each run started with a uniform prior distribution and a randomly chosen tree and, for each dataset, two runs with different starting trees were carried out to check convergence. The first 1001 trees of each run were discarded to allow the process to become stationary, leaving 19 000 trees for estimation of the probability distribution of trees contingent on the input alignment.
Detection of STAT1 by immunoblot analysis. 2fTGH or MDCK cells were infected with virus (m.o.i. 10) and incubated for 24-29 h prior to lysis in sample buffer [0?05 M Tris/HCl (pH 7?0), 0?2 % SDS, 5 % 2-mercaptoethanol, 5 % glycerol]. Cellular polypeptides were separated by SDS-PAGE. The proteins were then transferred to PVDF membranes and treated sequentially with a polyclonal antibody against STAT1 (catalogue no. G16930; Transduction Laboratories) and a secondary anti-rabbit antibody coupled to horseradish peroxidase (Amersham Biosciences). The membrane was treated with ECL detection reagents (Amersham Biosciences) and exposed to X-ray film. Prior to lysis, the infected cells were examined by immunofluorescence to confirm that >95 % cells were infected.
RESULTS
Human, canine, simian and porcine isolates of SV5 promote the degradation of STAT1 in human and canine cells
To determine whether the host range of the SV5 isolates might be restricted by their ability to block IFN signalling only in cells of the species from which they were isolated, their ability to target STAT1 for degradation in human and canine cells was examined. Cells were infected with the various isolates and when >95 % of the cells were positive for virus antigen as judged by immunofluorescence (usually by 24 h p.i.), the relative level of STAT1 in the infected cells was estimated by immunoblot analysis. All of the isolates tested, apart from CPI2 (which is known to be sensitive to IFN in both human and canine cells; Chatziandreou et al., 2002; Wansley & Parks, 2002) , induced STAT1 degradation in both human and canine cells (Fig. 1) .
Sequence variation in the V/P and F genes of human, canine, simian and porcine isolates of SV5
The V/P genes of the human (LN, MEL, MIL and DEN), canine (H221 and 78524) and porcine (SER) isolates were cloned and their nucleotide sequences were determined (see Table 1 for the origin of the various isolates used or reported (1998) in this study). The nucleotide sequences obtained and derived amino acid sequences (Table 2 ) of the V and P proteins were compared with the published sequence for the simian isolate W3A and a human isolate, termed cryptovirus, whose sequence has been deposited in GenBank (accession no. AX586923). This analysis established that there was only a low degree of variation within the V/P gene, with the amino acid variation ranging from 0?0 to 2?7 % for the V protein and from 0?5 to 2?8 % for the P protein. In the V protein, nearly all of the differences identified were in the V/P-common N-terminal domain, with only the cryptovirus isolate having a single amino acid difference in the V-unique domain (E 206 K). With regard to the P protein, the amino acid differences between the isolates were distributed throughout the protein.
Given the low sequence variation in the V/P proteins of the different isolates of SV5, it was of interest to ascertain whether this was also reflected in other viral proteins, especially those in which more variation might be expected due to the pressure of immune selection. We therefore determined the sequence of the F genes of the various virus isolates. The deduced amino acid sequences were compared with the published F protein sequences of the W3A, WR, SER, T1 (Paterson et al., 1984; Ito et al., 1997; Tong et al., 2002) and cryptovirus isolates (Table 3) . Comparison of the sequences again revealed a surprisingly low degree of variation, similar to that seen in the V/P gene, with amino acid variation ranging from 1?1 to 3?0 %. However, these percentages did not include the extended cytoplasmic tails that all of the isolates had, compared with W3A and WR. 
This extended tail has already been noted for T1 and SER isolates (Ito et al., 2000; Tong et al., 2002) . In all of the isolates apart from MEL, the cytoplasmic tail extension was 22 aa long, whilst in MEL it was only 5 aa long. This is thus in agreement with previously reported data showing that the F protein of MEL (also referred to as MN) migrated faster than those of the other human bone-marrow isolates LN, MIL and DEN on SDS-PAGE . 
Sequence comparisons between the isolates showed sporadic and more defined changes in comparison with W3A (Table 3) . Thus, for example, there were three amino acid changes that distinguished the four human bone-marrow isolates from all others: T 3 I, S 19 G and L 498 F. Alignment of the extended cytoplasmic tails also revealed two more amino acid changes that were unique to the human isolates: Q 530 and Q 536 (the latter not being present in the shorter extension of MEL). Interestingly, the M 310 I and S 438 T changes were common to the canine, porcine and cryptovirus isolates, as were the S 530 and R 536 amino acids within the extended cytoplasmic tail. The canine and porcine SER isolates also had the amino acid change E 132 K, relative to the other isolates. As might be expected, the two Glasgow canine isolates (H221 and 78524) appeared to be related more closely to each other than to the other isolates, although the next most closely related virus appeared to be the T1 canine isolate from Japan. Common to all the isolates was the S 443 P substitution, compared with W3A. In addition, all the isolates had an amino acid change at position 516, with the human and canine isolates having V 516 A, whereas the porcine SER isolate had V 516 T.
Phylogenetic analyses were carried out for the F and V/P genes by using the MrBayes 3 program. Independent runs for each dataset showed excellent convergence. Closely comparable results were obtained for both gene sets and only the results for the F gene are shown here. Fig. 2 shows the consensus tree obtained, in unrooted form. Most features in the tree were assigned maximum credibility values, with two lower values at central loci, indicating that the detail of branching in the core of the tree was not wellresolved. We presume that the root of the tree lies in or close to this central, unresolved region. On this basis, the isolates fell into five clades: (i) monkey and human isolates, except for cryptovirus; (ii) cryptovirus; (iii) German dog isolates CPI+ and CPI2; (iv) pig isolate SER; and (v) Japanese and Scottish dog isolates.
DISCUSSION
All of the isolates examined had an extended cytoplasmic tail in the F protein, compared with isolates W3A and WR, although this was only a 5 aa extension in the case of MEL, compared with a 22 aa extension in the other isolates.
Whether the short tail observed in W3A and WR is an adaptation to infection of monkeys or, as seems more likely, the result of laboratory selection of highly fusogenic and thus highly visible variants, remains to be established. Nevertheless, the observation that all isolates had an extended cytoplasmic tail that has been reported to reduce fusion activity (Tong et al., 2002; Seth et al., 2003) suggests that highly fusogenic viruses may be selected against in vivo. This contention was supported by the observation that both the W3A and WR isolates had the coding capacity for an extended tail, but that this was interrupted by a single nucleotide change that introduced a stop codon, resulting in truncation of the tail.
A primary reason for initiating these studies was to ascertain whether the host range of SV5 between dogs and humans might be restricted to the species from which they were isolated by their ability to block IFN signalling (Didcock et al., 1999a; Park et al., 2003) . However, apart from the previously documented case of CPI2, which fails to block IFN signalling in either canine or human cells (Chatziandreou et al., 2002) , all the isolates tested degraded STAT1 in both human and canine cells. Thus, the few amino acid substitutions identified in the N-terminal domain of V did not inhibit the ability of V to block IFN signalling. Also, there did not appear to be a clustering of nucleotide or amino acid changes, which might have been indicative of selection pressure on V function in blocking IFN signalling in cells from different species. It was also of note that, apart from cryptovirus with an E 206 K change, no amino acid substitutions mapped to the C-terminal domain of V, although there were nucleotide changes that altered the amino acid sequence within the P-unique domain that were encoded by the same region of the V/P gene that encodes the unique C-terminal domain of V. This is presumably because few amino acid changes can be tolerated in the highly conserved, cysteine-rich C-terminal domain of V.
Overall, there was a surprising lack of sequence variation at both the nucleotide and amino acid level between the various isolates of SV5, even though they were isolated from different species and geographical regions over a period of approximately 30 years. Indeed, the level of variation was similar to that observed for measles H and mumps and HPIV3 HN proteins (van Wyke Coelingh et al., 1988; Rima et al., 1997; Lim et al., 2003) , viruses whose host range is confined to man, and was significantly below that observed for the HN gene of Newcastle disease virus, a virus that infects many types of bird, including chickens and turkeys (Sakaguchi et al., 1989) . Within the F protein, in common with the porcine SER isolate, all of the canine isolates had an E 132 K change and, in common with both the porcine and cryptovirus isolates, also had M 310 I and S 438 T as well as S 530 and R 536 in their extended cytoplasmic tails. The canine viruses that were isolated in Glasgow (H221 and 78524) and Japan (T1) had I 4 R and A 135 V changes that were not found in the any of the other isolates, including CPI+, which was isolated from a dog in Germany. Interpretation of the SV5 trees based on nucleotide sequence comparisons of the P/V and F genes suggested that there are five lineages that emerge from the unresolved root. Interestingly, the Japanese T1 and Glasgow H221 and 78524 canine isolates appeared on the same branch as each other, but not with the German CPI canine viruses. In the placement of the root, the monkey (W3A and WR) and human bone-marrow viruses (but not cryptovirus) also formed a clade. Also consistent with this analysis, but as yet unproven, is the possibility that there is a division between the dog/pig and monkey/human isolates (Fig. 2) . Thus, there is clearly a requirement to sequence more variants of SV5 isolated from different species, in order to look more closely at underlying phylogenetic linkages.
From information published in the patent application relating to cryptovirus (WO02077211/EP1373477), it appears that this virus was a human isolate that may have come from a patient with neurological dysfunction. However, even though in the patent specifications it is claimed that this is a novel virus, this 'cryptovirus' did not show a significantly greater degree of difference from SV5 (2?25 % in F and 2?8 % in P) than any of the other isolates. None of the changes in 'cryptovirus', compared with W3A, were found in any of the human bone-marrow isolates (apart from those at aa 443 and 516 in F, which were common to all isolates, and 529, which was common to all isolates except WR), showing that, at least for the P and F proteins, there are no changes that might help to explain why these viruses were isolated from human tissues. With regard to the viruses that were isolated from human bonemarrow cells, they were clearly related most closely to each other. Thus, they all had the following changes: S 178 L in the P-unique domain, T 3 I, S 19 G, L 498 F and Q 530 in the F protein and H 533 and Q 536 in the extended cytoplasmic tail. However, there were also several identifying nucleotide and amino acid differences among the various bone-marrow isolates. Thus, the LN isolate had two unique amino acid differences in the V/P proteins and two in the F protein, whilst the MIL isolate had two unique amino acid differences in the V/P proteins and the MEL isolate had a unique amino acid in the F protein, together with an extended cytoplasmic tail of only 5 aa, as opposed to 22 aa for all other isolates. The fact that they are clearly related more closely to each other may not be surprising, as they were isolated at roughly the same time and from the same geographical region (London). Similarly, the two Glasgow canine isolates are also clearly related more closely to each other than to the other isolates. However, the sequence variation between the bone-marrow isolates suggested strongly that the viruses were isolated independently of each other, thereby all but ruling out the possibility that they were laboratory contaminants (Goswami et al., 1984) . If, as the weight of evidence now indicates, SV5 has been isolated regularly from bone-marrow cells in which the virus must presumably establish a persistent infection, then the reported isolation of SV5 from, or detection in, patients with a variety of diseases, including multiple sclerosis, subacute sclerosing panencephalitis (Robbins et al., 1981) , Creutzfeldt-Jakob disease (Horta-Barbosa et al., 1970) , pemphigus (Siegl & Hahn, 1969) , atherosclerosis (Behbehani et al., 1965 ), Paget's disease (Basle et al., 1985) , hepatitis (Hsiung, 1972; Liebhaber et al., 1965) and the common cold (Schultz & Habel, 1959) , should not be dismissed lightly, especially as in many cases great effort was made to rule out the possibility of contamination (Robbins et al., 1981; Goswami et al., 1984) . However, even if SV5 does cause persistent infections in humans, this does not necessarily mean that SV5 has a role to play in any human disease. Indeed, the wide spectrum of diseases from which SV5 has been isolated tends to argue against this. Furthermore, when examined in detail, as in the case of multiple sclerosis, the involvement of SV5 has been largely discounted. Nevertheless, if SV5 establishes persistent infections in a reasonable proportion of individuals, it may be timely to re-evaluate the role of SV5 and other paramyxoviruses in chronic human disease (Randall & Russell, 1991) , especially as we now have the tools to perform such studies more incisively. We also now know that SV5 and other paramyxoviruses interfere with cellular processes, including the IFN response and, thus, if there is a loss of cellular function in cells that are persistently infected with paramyxoviruses, the rationale behind any possible link with disease becomes easier to make.
The nomenclature of SV5 has always been problematic, given the repeated isolation of the virus over many years from numerous species. The problem is compounded because of a general assumption that if a virus is termed 'simian', then its natural host must be monkeys. To counter this assumption, new nomenclatures are creeping into use, such as SER virus and cryptovirus. However, these viruses are clearly no more different from the original W3A isolate than any of the other viruses we have examined. Furthermore, the virus is also often referred to as canine parainfluenza virus. Due to this confusion and reluctance by some authors to use the term SV5, we believe that it would be better to rename the virus parainfluenza virus 5 (PIV5), a nomenclature that was attempted in the late 1960s and early 1970s (Hsiung, 1972) . At the time, this probably failed because it was suggested that SV5 should be classified as parainfluenza virus 2 (PIV2) of monkeys (Chanock et al., 1961) . However, we now know from extensive antigenic and sequence analysis that SV5 and PIV2 are distinct viruses. The advantage of using the term PIV5 is that isolates can be prefixed with nomenclature that refers to the species from which they were isolated, e.g. canine PIV5 or porcine PIV5. However, a potential problem with giving a prefix to an isolate arises where there is doubt as to whether the virus was genuinely isolated from a given tissue or whether it arose as a laboratory contaminant, for example from the use of primary monkey kidney cells in the isolation procedure. Indeed, the knowledge that SV5 can contaminate primary monkey kidney cells is often a reason why diagnostic laboratories discount any isolation of SV5 from human tissues (M. Zambon, Health Protection Agency, Colindale, London, UK; personal communication). However, given the availability of specific reagents to SV5, including mAbs, it should be relatively easy to screen cell lines for the presence of SV5 and thus exclude any possibility of laboratory contamination during the isolation procedure or, if the virus was isolated in primary monkey kidney cells, to go back to the original specimen and try to re-isolate the virus in cell lines that are guaranteed to be free of the virus. There is thus a need to undertake further, well-controlled attempts to isolate SV5 from various human tissues and to determine the incidence of human infection with this virus.
